Loading...

FMTX - Forma Therapeutics Holdings, Inc.

Top Biomed Signal for 06-25-2022
Top Biomed Stock Signal: FMTX


Loading Chart FMTX

Stock Signal Information


Signal

Top Biomed Stock Signal: FMTX
Report Date: 06-25-2022
Symbol: FMTX - Forma Therapeutics Holdings, Inc.
Sector:
Industry:
Top Biomed Stock Signal: FMTX

  FMTX Technical Analysis

Company Contact

Forma Therapeutics Holdings, Inc. (FMTX)
500 Arsenal Street
Watertown, MA
Phone: 617 679 1970
Website: http://www.formatherapeutics.com
CEO: Mr. Frank D. Lee

FMTX, Forma Therapeutics Holdings, Inc.

FMTX Forma Therapeutics Holdings, Inc. Logo Image

NASDAQ, Nasdaq Global Market


Company Profile

Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobinopathies; and FT-7051 for the treatment of metastatic castration-resistant prostate cancer. The company is also developing FT-2102, an oral selective small molecule investigational agent that is designed to bind to and inhibit mutated IDH1 enzymes, which is being evaluated in a Phase 2 trial for relapsed/refractory AML, as well as an exploratory Phase 1 trial for glioma; and FT-4101 and FT-8225, which are selective fatty acid synthase inhibitors. The company was founded in 2007 and is headquartered in Watertown, Massachusetts.